Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-128-2013

Drug recall · January 23, 2013

CABERGOLINE Tablets recall

Why: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

Lots / codes

Lot number 6A007046V, exp 07/12

Quantity
13,232 bottles
Company
Teva Pharmaceuticals USA, Inc., Sellersville, PA
Distribution
Nationwide
Initiated
April 24, 2012 · Voluntary: Firm initiated
Classified
January 16, 2013
Reported
January 23, 2013
Ended
December 18, 2013
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Cabergoline

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.